登录 注册 会员服务 联系我们

Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma

  • Published:2010-05-24 Issue:5 Volume:5 Page:e10764
  • ISSN:1932-6203
  • Container-title:PLoS ONE
  • language:en
  • Short-container-title:PLoS ONE

Author:

Susa Michiro,Iyer Arun K.,Ryu Keinosuke,Choy Edwin,Hornicek Francis J.,Mankin Henry,Milane Lara,Amiji Mansoor M.,Duan Zhenfeng

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.;M Lourda;Int J Cancer,2007

2. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone.;CDM Fletcher,2002

3. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.;CL Schwartz;J Clin Oncol,2007

4. Chemotherapy resistance in osteosarcoma: current challenges and future directions.;AJ Chou;Expert Rev Anticancer Ther,2006

5. Tumour stem cells and drug resistance.;M Dean;Nat Rev Cancer,2005
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3